Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C17orf80 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | SLC12A6 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
mRNA | PTPRN | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
mRNA | MAGEB6P1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
mRNA | LRRC27 | CCLE | pan-cancer | AAC | -0.13 | 0.006 |
mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
mRNA | RPL11 | FIMM | pan-cancer | AAC | 0.53 | 0.006 |
mRNA | ETV1 | CCLE | pan-cancer | AAC | -0.15 | 0.006 |
mRNA | SECISBP2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | C1orf189 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |